Improved cine cardiovascular magnetic resonance using Clariscan™ (NC100150 injection)

Journal of Cardiovascular Magnetic Resonance

Volumn 3, Issue 4, 2001, Pages 303-310

  Bunce, N H ^a   Moon, J C C ^a   Bellenger, N G ^a   Keegan, J ^a   Grothues, F ^a   McCrohon, J A ^a   Francis, J M ^a   Smith, G C ^a   Burman, E D ^a   Firmin, D N ^a   Hoffmann, V W ^a   Pennell, D J ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cardiac function; Clariscan ; Short TR breathhold cine imaging

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; HEART EJECTION FRACTION; HEART FUNCTION; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; SIGNAL NOISE RATIO; SIGNAL PROCESSING;

AGED; AGED, 80 AND OVER; CONTRAST MEDIA; DIASTOLE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART DISEASES; HUMANS; IMAGE ENHANCEMENT; IRON; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; OXIDES; RESPIRATION; SYSTOLE; VENTRICULAR DYSFUNCTION;

EID: 18244373733     PISSN: 10976647     EISSN: None     Source Type: Journal    
DOI: 10.1081/JCMR-100108583     Document Type: Article

References (22)

1. Establishment and performance of a magnetic resonance cardiac function clinic
2. Left ventricular function and mass after orthotopic heart transplantation: A comparison of cardiovascular magnetic resonance with echocardiography
3. Comparison of left ventricular ejection fraction and volumes in heart failure by two-dimensional echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance: Are they interchangeable?
4. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance
5. Normal left ventricular dimensions and function: Interstudy reproducibility of measurements with cine MR imaging
6. Differences between normal subjects and patients with coronary artery disease for three different MR coronary angiography respiratory suppression techniques
7. Magnetic resonance imaging during dobutamine stress in coronary artery disease
8. Assessment of magnetic resonance velocity mapping of global ventricular function during dobutamine infusion in coronary artery disease
9. Three-dimensional cardiac cine magnetic resonance imaging with an ultrasmall superparamagnetic iron oxide blood pool agent
10. Improved cine magnetic resonance imaging of the left ventricular wall motion using gadopentetate-dimeglumine
11. Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography
12. Use of the intravascular contrast agent NC100150 injection in spin echo and gradient echo imaging of the heart
13. First-pass myocardial perfusion imaging and equilibrium signal changes using the intravascular contrast agent NC100150 injection
14. NC100150 injection
15. Measuring signal-to-noise ratios in MR imaging
16. Assessing contrast on MR images
17. Normal human right and left ventricular mass, systolic function and gender differences by cine magnetic resonance imaging
18. Comparison of 201T1, 99mTc-tetrofosmin, and dobutamine magnetic resonance imaging for identifying hibernating myocardium
19. MR features of arrhythmogenic right ventricular dysplasia
20. Fast field echo imaging: An overview and contrast calculations
21. Abdominal vessel enhancement with an ultrasmall, superparamagnetic iron oxide blood pool agent: Evaluation of dose and echo time dependence at difference
22. Left ventricular quantification in heart failure by CMR using prospective respiratory navigator gating: Comparison with breath-hold acquisition